D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
Kimberly-Clark
KMB
$37.6B
| $9.67M | 0.01% |
+75,000
| New | +$10.2M |
|
1427
ESAB
ESAB
$5.37B
| $9.67M | 0.01% |
80,201
+76,510
| +2,073% | +$9.25M |
|
1428
Ardelyx
ARDX
$1.24B
| $9.64M | 0.01% |
2,458,666
+542,141
| +28% | +$2.24M |
|
1429
PUT
Lithia Motors
LAD
$9.75B
| $9.63M | 0.01% |
28,500
+4,600
| +19% | +$1.42M |
|
|
SLNO
1430
DELISTED
Soleno Therapeutics
SLNO
| $9.61M | 0.01% |
114,690
+98,018
| +588% | +$7.34M |
|
1431
Upbound Group
UPBD
$1.22B
| $9.61M | 0.01% |
382,691
-122,552
| -24% | -$2.86M |
|
|
EHAB
1432
DELISTED
Enhabit
EHAB
| $9.59M | 0.01% |
995,185
+91,980
| +10% | +$849K |
|
1433
Unisys
UIS
$252M
| $9.59M | 0.01% |
2,116,107
+284,407
| +16% | +$1.28M |
|
1434
MKS Inc
MKSI
$17.4B
| $9.57M | 0.01% |
96,288
-296,093
| -75% | -$24.1M |
|
1435
PUT
Regeneron Pharmaceuticals
REGN
$72.9B
| $9.55M | 0.01% |
18,200
-5,400
| -23% | -$3.01M |
|
|
SOUL
1436
Soulpower Acquisition Corp
SOUL
$352M
| $9.54M | 0.01% |
+950,000
| New | +$9.47M |
|
1437
Datadog
DDOG
$94B
| $9.51M | 0.01% |
+70,793
| New | +$7.84M |
|
1438
CALL
Affirm
AFRM
$23.5B
| $9.49M | 0.01% |
137,200
-375,100
| -73% | -$19.4M |
|
1439
Fulgent Genetics
FLGT
$558M
| $9.47M | 0.01% |
476,488
+36,472
| +8% | +$711K |
|
1440
PUT
Expedia Group
EXPE
$36.5B
| $9.46M | 0.01% |
56,100
+26,100
| +87% | +$4.23M |
|
|
SWTX
1441
DELISTED
SpringWorks Therapeutics
SWTX
| $9.45M | 0.01% |
201,100
-1,462,383
| -88% | -$65.1M |
|
1442
CALL
BP
BP
$112B
| $9.45M | 0.01% |
315,600
+110,300
| +54% | +$3.24M |
|
1443
MannKind Corp
MNKD
$1.19B
| $9.43M | 0.01% |
2,522,678
-1,314,956
| -34% | -$5.79M |
|
1444
Consensus Cloud Solutions
CCSI
$675M
| $9.43M | 0.01% |
408,979
-96,021
| -19% | -$2.07M |
|
1445
Insight Enterprises
NSIT
$3.85B
| $9.43M | 0.01% |
68,294
+35,069
| +106% | +$4.72M |
|
1446
JELD-WEN Holding
JELD
$110M
| $9.42M | 0.01% |
2,404,287
+1,042,466
| +77% | +$4.65M |
|
1447
C3.ai
AI
$1.38B
| $9.41M | 0.01% |
382,870
-740,623
| -66% | -$16.9M |
|
1448
Baker Hughes
BKR
$58.3B
| $9.4M | 0.01% |
245,289
+13,115
| +6% | +$495K |
|
1449
Omega Healthcare
OHI
$15.3B
| $9.38M | 0.01% |
255,909
+65,831
| +35% | +$2.44M |
|
|
EWCZ
1450
DELISTED
European Wax Center
EWCZ
| $9.38M | 0.01% |
1,665,803
+397,121
| +31% | +$1.8M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.